In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.
--------
Question: End Abuse in Later Life Act of 2011 - Amends the Violence Against Women Act of 1994 to authorize appropriations for and revise provisions governing the grant program to end abuse of individuals age 50 and over that is authorized to be conducted by the Attorney General through the Director of the Office of Violence Against Women.

Makes currently listed activities mandatory for grant recipients and sets forth as additional permissible activities: (1) providing training programs to assist attorneys, health care providers, faith-based leaders, or other community-based organizations in recognizing and addressing instances of such abuse; and (2) conducting outreach activities and public awareness campaigns to ensure that abuse victims receive appropriate assistance.

Includes as eligible entities: (1) a population-specific organization with demonstrated experience in assisting individuals over 50 years of age; (2) a victim service provider with demonstrated experience in addressing domestic violence, dating violence, sexual assault, and stalking; or (3) a state, tribal, or territorial domestic violence or sexual assault coalition. Requires each eligible entity to demonstrate that it is a part of a multidisciplinary partnership that includes a law enforcement agency, a prosecutor's office, a victim service provider, and a nonprofit program or government agency with demonstrated experience in assisting individuals in later life.

Directs the Attorney General to: (1) give priority to proposals providing population-specific services to racial and ethnic minorities and other underserved populations; and (2) conduct research to promote understanding of, prevention of, and response to abuse in later life.

Amends the Violence Against Women Act of 1994 to replace the term "elder law" with "abuse in later life."

Answer: A bill to establish a grant program to enhance training and services to prevent abuse in later life.


Question: Justice for the Victims of Pan Am 103 Act of 2001 - Expresses the sense of Congress that: (1) the Government of Libya and its leader, Moammar Gaddafi, should be condemned for support of international terrorism, including the bombing of Pan Am 103; (2) the Government of Libya should make a full apology for the bombing of Pan Am 103 and provide adequate compensation to the families of the victims; and (3) the President, the Secretary of State, and other Government officials should encourage other countries to maintain international sanctions (including United Nations (UN) sanctions) against Libya until the requirements of this Act are met.Declares it shall be U.S. policy to oppose the removal of UN sanctions, U.S. sanctions, the travel ban, and all other U.S. restrictions on Libya until certain conditions with respect to Libya and international terrorism and Pan Am 103 are met. Prohibits U.S. assistance to the Government of Libya until the President certifies to specified congressional committees that such conditions are met.

Answer: A bill to provide for United States policy toward Libya.


Question: Verifying Authority and Legality In Drug Compounding Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) with respect to the regulation of compounding drugs.

Eliminates authority for compounding pharmacies to: (1) compound drugs before the receipt of a valid prescription order, or (2) compound any drug product that is a copy of a commercially available drug.

Requires the Secretary of Health and Human Services (HHS) to develop, maintain and transmit to the appropriate state agencies a list of drug products that should not be compounded, including: (1) drug products whose compounding is reasonably likely to cause an adverse effect on their safety or effectiveness; and (2) drug products that have been withdrawn or removed from the market because they have been found to be unsafe or not effective.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if compounding the drug product is necessary to address a drug shortage, or to protect public health or well-being. Prohibits the Secretary from authorizing a state to grant such waivers.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if the pharmacy or pharmacist: (1) submits a satisfactory application to the Secretary; and (2) agrees to comply with any condition or limitation specified by the Secretary. Makes a pharmacy or pharmacist required to be registered under the FFDCA as a drug producer ineligible for a waiver. Permits the Secretary to authorize a state to grant such waivers applicable to compounded drug products sold or dispensed within the state pursuant to a memorandum of understanding between the Secretary and the state.

Authorizes the Secretary to waive the prohibition against compounding any drug product that is a copy of a commercially available drug if it is necessary to protect public health or well-being. Prohibits the Secretary from authorizing a state to waive such prohibition.

Subjects the facilities of any pharmacy receiving a waiver under this Act to inspection to determine compliance with this Act.

Requires the Secretary to publish notice at least 30 days before cancelling a waiver, unless it is necessary to prevent an adverse impact on public health or safety.

Sets forth a required label statement for any drug compounded pursuant to this Act.

 Requires a pharmacist or physician compounding a drug product to report any adverse event associated with the use of the product within a specified time frame.

Answer:
To amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products.